Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo

Journal of Experimental Medicine

Volumn 177, Issue 5, 1993, Pages 1239-1246

  Gonzalo, José Angel ^a   González García, Ana ^a   Martínez A, Carlos ^a   Kroemer, Guido ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTERONE; CYCLOSPORIN A; DEXAMETHASONE; GALACTOSAMINE; MIFEPRISTONE; STAPHYLOCOCCUS ENTEROTOXIN B;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE CLONE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIGENS; CELL DEATH; CLONE CELLS; DEXAMETHASONE; ENTEROTOXINS; GLUCOCORTICOIDS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MIFEPRISTONE; SPLEEN; STAPHYLOCOCCUS AUREUS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0027465502     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.5.1239     Document Type: Article

References (39)

1. Bateman, A., A. Singh, T. Krai, and S. Solomon. 1989. The immune-hypothalamic-pituitary-adrenal axis. Endocrine Rev. 10:92.
2. Wick, G., and G. Kroemer. 1993. The immune-hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrine Rev. In press.
3. Vacca, A., M.P. Felli, A.R. Farina, S. Martinotti, M. Maroder, I. Screpanti, D. Meco, E. Petrangeli, L. Freti, and A. Gulino. 1992. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooper-ativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp Med. 175:637.
4. Daynes, R.A., and B.A. Araneo. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol 19:2319.
5. Golstein, P., D.M. Ojcius, and J.D.-E. Young. 1991. Cell death mechanisms and the immune system. Immunol. Rev. 121:29.
6. Cohen, I.J., R.C. Duke, V.A. Fadok, and K.S. Sellins. 1992. Apoptosis and programmed cell death in immunity. Amu. Rev. Immunol. 10:267.
7. Zubiaga, A.M., E. Munoz, and B.T. Huber. 1992. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J. Immunol. 149:107.
8. Chensue, S.W., P.D. Terebuh, D.G. Remick, W.E. Scales, and S.L. Kunkel. 1991. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta, and tumor necrosis factor during experimental endotoxinemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 138:395.
9. Kroemer, G., H.-P. Brezinschek, R. Faessler, K. Schauenstein, and G. Wick. 1988. Physiology and pathology of an immunoen-docrine feedback loop. Immunol. Today. 9:163.
10. Sternberg, E.M., W.S. Young III, R. Bernardini, A.E. Calogero, G.P. Chrousos, P.W. Gold, and R.L. Wilder. 1989. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Set. USA. 86:4771.
11. MacPhee, I.A.M., F.A. Antoni, andD.W. Mason. 1989. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous corticosteroids. J. Exp Med. 169:431.
12. Derijk, R., and F. Berkenbosch. 1991. The immune-hypo-thalamo-pituitary adrenal axis and autoimmunity. Int. J. Neurosci. 59:91.
13. Rodger, M.W., and D.T. Baird. 1987. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary. Lancet. 2:1415.
14. Glasier, A., K.J. Thong, M. Dewar, M. Mackie, and D.T. Baird. 1992. Mifepristone (RU 486) compared with high-dose estrogen and progesterone for emergency postcoital contraception. N. Engl. J. Med. 327:1041.
15. Lamberts, S.W.J., J.W. Koper, and F.H. dejong. 1992. Longterm treatment with RU486 and glucorticoid receptor resistance. Theoretical and therapeutic implications. Trends En-drocrinol. Metab. 3:199.
16. Leo, O., W. Foo, D.H. Sachs, L.E. Samelson, and J. Bluestone. 1986. Identification of a monoclonal antibody specific for a murine CD3 polypeptide. Proc Natl. Acad. Set. USA. 134:1374.
17. Kanagawa, O. 1989. In vivo T cell tumor therapy with monoclonal antibody directed to the V/3 chain of T cell antigen receptor. J. Exp Med. 170:1513.
18. Staerz, U., H.G. Rammensee, J.D. Benedeto, and M.J. Bevan. 1987. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134:3994.
19. Andreu-Sinchez, J.L., I. Moreno de Alboran, M.A.R. Marcos, A. Sdnchez-Movilla, C. Martinez-A, and G. Kroemer. 1991. IL-2 abrogates the non-responsive state of T cells expressing a forbidden TCR repertoire and induces autoimmune disease in neonatally thymectomized mice. J. Exp Med. 173:1323.
20. Gonzalo, J.A., I. Moreno de Alborin, J.E. Ales-Martinez, C. Martinez-A., and G. Kroemer. 1992. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin 2 pathway. Eur. J. Immunol. 22:1007.
21. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature (Lond.). 349:245.
22. Alegre, M.-L., P. Vandenabeele, M. Depierreux, S. Florquin, M. Deschodt-Lanckman, V. Flamand, N. Moserm, O. Leo, J. Urbain, W. Fiers, and M. Goldman. 1991. Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylpredniso-lone. J. Immunol. 146:1184.
23. Brouckaert, P., B. Everaerdt, and W. Fiers. 1992. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor. Eur. J. Immunol. 22:981.
24. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P.H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp Med. 175:91.
25. Marrack, P., M. Blackman, E. Kushnir, andj. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp Med. 171:455.
26. + T cells by conventional antigen and Mis superantigens. Proc. Natl. Acad. Sci. USA. 88:2736.
27. O’Rourke, A.M., M.F. Mescher, and S.R. Webb. 1990. Activation of phosphoinositide hydrolysis in T cell by H-2 alloantigen but not MLS determinants. Science (Wash. DC). 249:171.
28. Rotello, R.J., R.C. Lieberman, R.B. Lepoff, and L.E. Ger-schenson. 1992. Characterization of uterine epithelium apop-totic cell death kinetics and regulation by progesterone and RU 486. Am. J. Pathol. 140:449.
29. Jacobson, L., and R. Sapolsky. 1991. The role for the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocrine Rev. 12:118.
30. Heeg, K., T. Miethke, and H. Wagner. 1992. Lymphokine release during T-cell mediated lethal shock: initial lymphokine burst is followed by a failure to produce interleukin 2 and TNF. 8th Int. Congr. Immunol. 35.17 (Abstr.).
31. White, J., A. Herman, A.M. Pullen, R. Kubo, J.W. Kappler, and P. Marrack. 1989. The V/3-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 56:27.
32. + peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur. J. Immunol. 21:1963.
33. Alexandrova, M. 1992. Duration of antagonizing effect of RU486 on the agonist induction of tyrosine aminotransferase via glucorticoid receptor./. Steroid. Biochem. Mol. Biol. 41:723.
34. Zacharchuk, C., M. Mercep, P.K. Chakraborti, S.S.J. Simons, and J.D. Ashwell. 1990. Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145:4037.
35. Iwata, M., S. Hanaoka, and K. Sato. 1991. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur. J. Immunol 21:643.
36. Vanier, L.E., and G.J. Prud’homme. 1992. Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction. J. Exp Med. 176:37.
37. Butler, L.D., N.K. Layman, P.E. Riedl, R.L. Cain, J. Shellhaas, G.F. Evans, and S.FL Zuckerman. 1989. Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha. J. Neuroimmunol. 24:143.
38. Besedovsky, H.O., A. del Rey, I. Klusman, FI. Furukawa, G. Monge-Arditi, and A. Kabiersch. 1991. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid. Bio-chem. Mol. Biol. 40:613.
39. Cohen, J., and M.P. Glauser. 1991. Septic shock: treatment. Lancet. 2:736.